CERVICAL SQUAMOUS CELL CARCINOMA
Clinical trials for CERVICAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new weapon against advanced gynecologic cancers
Disease control OngoingThis large, late-stage trial is testing whether adding an experimental drug called triapine to the standard treatment of radiation and chemotherapy improves survival for women with advanced cervical or vaginal cancer. The study will enroll 450 women to compare the new three-part …
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC
-
New oral drug trial offers hope for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new oral medication called BBI-355, both alone and in combination with other drugs, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the treatment can shrink…
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New cancer combo enters safety testing for dozens of tumor types
Disease control OngoingThis early-stage trial is testing the safety and finding the right dose of a two-drug combination (naptumomab estafenatox and durvalumab) for people with advanced or metastatic solid tumors. It will enroll about 120 adults with one of many eligible cancer types, including breast,…
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: NeoTX Therapeutics Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC